As filed with the Securities and Exchange Commission on February 8, 2007

Registration No. 333-_____

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

---

FORM S-3

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

---

Immtech Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

 

---

One North End Avenue

New York, NY 10282

(212) 791-2911

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

---

 

Eric L. Sorkin

Chief Executive Officer

Immtech Pharmaceuticals, Inc.

One North End Avenue

New York, NY 10282

(212) 791-2911

 

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copy To:

Elizabeth Brower, Esq.

Paul, Hastings, Janofsky & Walker LLP

1055 Washington Boulevard

Stamford, CT 06901

(203) 961-7400

 

 

---

Approximate date of commencement of sale of the securities to the public:

As soon as practicable after this registration statement becomes effective.

 

If the only securities being registered on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. [     ]

If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. [     ]

If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ X ] 333-130970

If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [     ] ___________________

If this form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. [     ]

If this form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. [     ]

 

 

 

 

---

 

EXPLANATORY NOTE

This registration statement is being filed to register additional shares of common stock of Immtech Pharmaceuticals, Inc. pursuant to Rule 462(b) under the Securities Act of 1933, as amended. A Registration Statement on Form S-3, Commission File No. 333-130970 (the “Prior Registration Statement”), to which this registration statement relates was declared effective by the Securities and Exchange Commission on February 7, 2006. The contents of the Prior Registration Statement are incorporated herein by reference.

 

 

 

 

---

 

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

 

 

 

 

 

 

---

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of New York, State of New York, on the 7th day of February, 2007.

 

 

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

 

 

 

---

 

EXHIBIT INDEX

 

 

 

 

---